# A New Study Evaluating the Activity of Modular CAR T for mYeloma

> **NCT04795882** · PHASE1 · RECRUITING · sponsor: **University College, London** · enrollment: 27 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** BCMA CAR T cells
- **BIOLOGICAL:** BCMA/CD19 CAR T cells

## Key facts

- **NCT ID:** NCT04795882
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-22
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04795882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04795882, "A New Study Evaluating the Activity of Modular CAR T for mYeloma". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04795882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*